- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 90.32M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 90.25M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 86.05M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 72.03M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 70.76M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $3.95M |
| Capex | Q3 2025 · Sep 30, 2024 | $2.53M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$39.47M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$32.94M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $39.73M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $28.91M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $33.35M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $54.19M |
| Short Term Investments restated | Q3 2025 · Sep 30, 2024 | $52.8M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $25.35M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $19.26M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $37.45M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $38.54M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $55.63M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $66.93M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $73.4M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $61.45M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $86.62M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $18.48M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $23.65M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $85.42M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $82.08M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $76.19M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $98.77M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $123.96M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $149.01M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.22 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.62 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.29 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.78 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.22 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.62 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.29 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.78 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $11.22M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $35.89M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $13.57M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $42.1M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $13.87M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $40.59M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $11.51M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $34.16M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$19.62M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$53.58M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$20.64M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$54.9M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$18.95M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$52.3M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$16.56M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$51.18M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.47M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $7.3M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $4.32M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $12.63M |
| Revenue | Q3 2025 · Sep 30, 2025 | $8.6M |
| Revenue | Q3 2025 · Sep 30, 2025 | $31.47M |
| Revenue | Q3 2025 · Sep 30, 2024 | $12.83M |
| Revenue | Q3 2025 · Sep 30, 2024 | $37.89M |